AFT Pharmaceuticals (AFT Pharmaceuticals) FCF Margin % : 14.98% (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is AFT Pharmaceuticals FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. AFT Pharmaceuticals's Free Cash Flow for the three months ended in Mar. 2024 was $10.17 Mil. AFT Pharmaceuticals's Revenue for the three months ended in Mar. 2024 was $67.87 Mil. Therefore, AFT Pharmaceuticals's FCF Margin % for the quarter that ended in Mar. 2024 was 14.98%.

As of today, AFT Pharmaceuticals's current FCF Yield % is 6.47%.

The historical rank and industry rank for AFT Pharmaceuticals's FCF Margin % or its related term are showing as below:

During the past 9 years, the highest FCF Margin % of AFT Pharmaceuticals was 9.94%. The lowest was -27.72%. And the median was -2.82%.

AFTPF's FCF Margin % is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 0.25
* Ranked among companies with meaningful FCF Margin % only.

AFT Pharmaceuticals FCF Margin % Historical Data

The historical data trend for AFT Pharmaceuticals's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AFT Pharmaceuticals FCF Margin % Chart

AFT Pharmaceuticals Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

FCF Margin %

Get a 7-Day Free Trial

7.88

-4.85

6.60

1.57

9.94

AFT Pharmaceuticals Quarterly Data
	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24
FCF Margin %	Get a 7-Day Free Trial												6.05	1.72	1.46	3.16	14.98

Competitive Comparison of AFT Pharmaceuticals's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, AFT Pharmaceuticals's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AFT Pharmaceuticals's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AFT Pharmaceuticals's FCF Margin % distribution charts can be found below:

* The bar in red indicates where AFT Pharmaceuticals's FCF Margin % falls into.

AFT Pharmaceuticals FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

AFT Pharmaceuticals's FCF Margin for the fiscal year that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Mar. 2024 )	/	Revenue (A: Mar. 2024 )
	=	11.76	/	118.347
	=	9.94 %

AFT Pharmaceuticals's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	10.165	/	67.867
	=	14.98 %

AFT Pharmaceuticals FCF Margin % Related Terms

Thank you for viewing the detailed overview of AFT Pharmaceuticals's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

AFT Pharmaceuticals (AFT Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AFT Pharmaceuticals Ltd (OTCPK:AFTPF) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

AFT:New Zealand AFP:Australia

Address

129 Hurstmere Road, Level 1, Takapuna, Auckland, NTL, NZL, 0622

Website

https://www.aftpharm.com

AFT Pharmaceuticals Ltd is a pharmaceutical distributor and developer of pharmaceutical intellectual property. Some of the products of the organization are Aqueous cream, Calci-tab, Maxigesic, Cromo-fresh, Crystaderm, Crytawash, Ellgy plus, Emulsifying ointment, and others. The group has four operating segments based on geographical location being, Australia, New Zealand, Asia, and the Rest of the world. It generates the majority of the revenue from Australia which includes the sales and distribution activity relating to the Australian market.